Loading patent…
AssigneesJiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
InventorsXing Sun, Zhuoxiao Cao, Zupeng Xu, Cheng Liao, Changyong Yang, Lianshan Zhang
Estimating the term…
Disclosed is use of a TIM-3 antibody in preparation of medicines for treating tumors. Specifically, provided is use of the TIM-3 antibody or an antigen-binding fragment thereof in preparation of medicines for treating non-small cell lung cancer, the TIM-3 antibody containing a heavy chain variable region shown in SEQ ID NO: 33 and a light chain variable region shown in SEQ ID NO: 36. Further, also provided is use of the TIM-3 antibody or the antigen-binding fragment thereof and a PD-1 antibody or an antigen-binding fragment thereof in joint preparation of medicines for treating tumors.
A method of treating a tumor in a patient in need thereof, the method comprising administering to the patient a therapeutically effective amount of a TIM-3 antibody or antigen-binding fragment thereof.
A pharmaceutical composition, comprising an anti-TIM-3 antibody or antigen-binding fragment thereof, and an anti-PD-1 antibody or antigen-binding fragment thereof.
Dependencies are inferred from the claim text.